Dimerix Limited (SBMJF)
OTCMKTS
· Delayed Price · Currency is USD
0.3500
0.00 (0.00%)
At close: Jun 4, 2025
Dimerix Revenue
Dimerix had revenue of 287.45K AUD in the half year ending December 31, 2024. This brings the company's revenue in the last twelve months to 737.87K, up 334.43% year-over-year. In the fiscal year ending June 30, 2024, Dimerix had annual revenue of 583.48K with 1,486.10% growth.
Revenue (ttm)
737.87K AUD
Revenue Growth
+334.43%
P/S Ratio
440.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
201.11M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 583.48K | 546.69K | 1,486.10% |
Jun 30, 2023 | 36.79K | -6.43M | -99.43% |
Jun 30, 2022 | 6.46M | 2.02M | 45.58% |
Jun 30, 2021 | 4.44M | 2.10M | 89.65% |
Jun 30, 2020 | 2.34M | 893.56K | 61.74% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |